Design and development of a soluble PDA-Emodin-PVP-MN patch and its anti-obesity effect in rats
Drug Delivery and Translational Research · 2025
DOI: 10.1007/s13346-024-01623-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Haijiao Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy & State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Obesity, Indoles, Anti-Obesity Agents, Emodin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Technology Innovation Guide Project of Gansu Province, China, Lanzhou University Innovation and Entrepreneurship Cultivation Program, China, Cultivation Project of Medical Student Innovation and Entrepreneurship Competition of Lanzhou University Medical Science Department, China.
Abstract (Originalsprache)
Emodin has been proven to have weight-reducing and lipid-lowering effects. In order to make emodin play a better anti-obesity role, we designed and developed an emodin loaded dissolving microneedle patch, in which emodin existed in the form of emodin-polyvinylpyrrolidone co-precipitate (Emodin-PVP). Meanwhile, polydopamine (PDA) was added to the microneedle patch (PDA-Emodin-PVP-MN) for photothermal-enhanced chemotherapy of obesity. The average weight of the patch was 0.1 ± 0.05 g and the drug loading was 0.37 ± 0.031 mg. After 5 min of NIR irradiation (808 nm, 0.6 W/cm2), the rat abdominal temperature could reach 48 ℃, and the cumulative release of emodin reached 96.25%. The diffusion coefficient of emodin in the in vitro agar diffusion experiment was 249.27 mm2 h-1. No obvious toxicity was observed in hemolysis test, CCK-8 assay and microscopic histopathological analysis. The patch significantly reduced the percent of body weight ( P < 0.01), lipid-body ratio ( P < 0.001), serum FFAs ( P < 0.01) and the cell volume of peritesticular adipose tissue in the high-fat diet induced obese rats, indicating the patch had good anti-obesity effect. The mechanism of action may be related to the up-regulation of HSL and LPL protein levels in rat peritesticular adipose tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy & State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, 730000, China.
- Collaborative Innovation Center for Northwestern Chinese Medicine, Lanzhou University, Lanzhou, 730000, China.
- School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China.
- School of Pharmacy & State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, 730000, China. shiyb@lzu.edu.cn.
- Collaborative Innovation Center for Northwestern Chinese Medicine, Lanzhou University, Lanzhou, 730000, China. shiyb@lzu.edu.cn.
ORCID-Profile: Yanbin Shi
Förderung
- Technology Innovation Guide Project of Gansu Province, China
- Lanzhou University Innovation and Entrepreneurship Cultivation Program, China
- Cultivation Project of Medical Student Innovation and Entrepreneurship Competition of Lanzhou University Medical Science Department, China
Zitieren
APA
Wang, H., Wang, L., Wang, M., Niu, J., Yang, B., Wang, Y., An, M., Sun, X., Yang, Z., Li, X., & Shi, Y. (2025). Design and development of a soluble PDA-Emodin-PVP-MN patch and its anti-obesity effect in rats. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01623-9
Vancouver
Wang H, Wang L, Wang M, Niu J, Yang B, Wang Y, et al. Design and development of a soluble PDA-Emodin-PVP-MN patch and its anti-obesity effect in rats. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01623-9
BibTeX
@article{Wang2025,
author = {Wang, Haijiao and Wang, Lifang and Wang, Meng and Niu, Jingjing and Yang, Bowen and Wang, Yinxiong and An, Min and Sun, Xiuxia and Yang, Zhigang and Li, Xuefeng and Shi, Yanbin},
title = {Design and development of a soluble PDA-Emodin-PVP-MN patch and its anti-obesity effect in rats},
journal = {Drug Delivery and Translational Research},
year = {2025},
doi = {10.1007/s13346-024-01623-9}
}
EUVIMED